Riko Matsumoto (11824673)
12  results:
Search for persons X
?
1

Full-length western blot images of recombinant human VEGF-A..:

Yusuke Ichiyama (11237783) ; Riko Matsumoto (11824673) ; Shumpei Obata (11237777)...
https://figshare.com/articles/figure/Full-length_western_blot_images_of_recombinant_human_VEGF-A_sub_165_sub_and_mouse_VEGF-A_sub_164_sub_detected_with_aflibercept_or_ranibizumab_as_the_primary_antibody_/21764711.  , 2022
 
?
2

The effect of intravitreal injection of ranibizumab and afl..:

Yusuke Ichiyama (11237783) ; Riko Matsumoto (11824673) ; Shumpei Obata (11237777)...
https://figshare.com/articles/figure/The_effect_of_intravitreal_injection_of_ranibizumab_and_aflibercept_on_oxygen_induced_retinopathy_/21764720.  , 2022
 
?
3

Full-length western blot images of recombinant human VEGF-A..:

Yusuke Ichiyama (11237783) ; Riko Matsumoto (11824673) ; Shumpei Obata (11237777)...
https://figshare.com/articles/figure/Full-length_western_blot_images_of_recombinant_human_VEGF-A_sub_121_sub_and_mouse_VEGF-A_sub_120_sub_detected_with_aflibercept_or_ranibizumab_as_the_primary_antibody_/21764714.  , 2022
 
?
4

The effect of ranibizumab and aflibercept injected intraper..:

Yusuke Ichiyama (11237783) ; Riko Matsumoto (11824673) ; Shumpei Obata (11237777)...
https://figshare.com/articles/figure/The_effect_of_ranibizumab_and_aflibercept_injected_intraperitoneally_into_neonatal_mice_/21764723.  , 2022
 
?
5

Western blot analysis of the interaction of recombinant hum..:

Yusuke Ichiyama (11237783) ; Riko Matsumoto (11824673) ; Shumpei Obata (11237777)...
https://figshare.com/articles/figure/Western_blot_analysis_of_the_interaction_of_recombinant_human_VEGF-A_sub_165_sub_and_mouse_VEGF-A_sub_164_sub_human_VEGF-A_sub_121_sub_and_mouse_VEGF-A_sub_120_sub_with_aflibercept_or_ranibizumab_as_the_primary_antibody_/21764726.  , 2022
 
?
6

S1 Raw images -:

Yusuke Ichiyama (11237783) ; Riko Matsumoto (11824673) ; Shumpei Obata (11237777)...
https://figshare.com/articles/journal_contribution/S1_Raw_images_-/21764717.  , 2022
 
?
7

Baseline characteristics of the two groups after 1:1 matchi..:

Shumpei Obata (11237777) ; Yusuke Ichiyama (11237783) ; Riko Matsumoto (11824673)...
https://figshare.com/articles/dataset/Baseline_characteristics_of_the_two_groups_after_1_1_matching_for_body_weight_at_treatment_within_100_g_/17160317.  , 2021
 
?
8

BW pre- and post-treatment:

Shumpei Obata (11237777) ; Yusuke Ichiyama (11237783) ; Riko Matsumoto (11824673)...
https://figshare.com/articles/figure/BW_pre-_and_post-treatment_/17160299.  , 2021
 
?
9

Patient flow diagram:

Shumpei Obata (11237777) ; Yusuke Ichiyama (11237783) ; Riko Matsumoto (11824673)...
https://figshare.com/articles/figure/Patient_flow_diagram_/17160293.  , 2021
 
?
10

Parameters other than BW gain:

Shumpei Obata (11237777) ; Yusuke Ichiyama (11237783) ; Riko Matsumoto (11824673)...
https://figshare.com/articles/figure/Parameters_other_than_BW_gain_/17160311.  , 2021
 
?
11

Effect of Pre-treatment BW on BW gain post-treatment:

Shumpei Obata (11237777) ; Yusuke Ichiyama (11237783) ; Riko Matsumoto (11824673)...
https://figshare.com/articles/figure/Effect_of_Pre-treatment_BW_on_BW_gain_post-treatment_/17160305.  , 2021
 
?
12

Data set for analysis:

Shumpei Obata (11237777) ; Yusuke Ichiyama (11237783) ; Riko Matsumoto (11824673)...
https://figshare.com/articles/dataset/Data_set_for_analysis_/17160287.  , 2021
 
1-12